Copyright Reports & Markets. All rights reserved.

Global In-vitro Diagnostics Enzymes Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Market Analysis by Type
    • 1.3.1 Global In-vitro Diagnostics Enzymes Market Size Growth Rate by Type: 2020 VS 2026
    • 1.3.2 Proteases
    • 1.3.3 Polymerase & Transcriptase
    • 1.3.4 Ribonuclease
    • 1.3.5 Others
  • 1.4 Market by Application
    • 1.4.1 Global In-vitro Diagnostics Enzymes Market Share by Application: 2020 VS 2026
    • 1.4.2 Pharma & Biotech
    • 1.4.3 Hospital & Diagnostic Labs
    • 1.4.4 Contract Research Organizations (CROs)
    • 1.4.5 Academic Labs
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global In-vitro Diagnostics Enzymes Market Perspective (2015-2026)
  • 2.2 In-vitro Diagnostics Enzymes Growth Trends by Regions
    • 2.2.1 In-vitro Diagnostics Enzymes Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 In-vitro Diagnostics Enzymes Historic Market Share by Regions (2015-2020)
    • 2.2.3 In-vitro Diagnostics Enzymes Forecasted Market Size by Regions (2021-2026)
  • 2.3 In-vitro Diagnostics Enzymes Industry Dynamic
    • 2.3.1 In-vitro Diagnostics Enzymes Market Trends
    • 2.3.2 In-vitro Diagnostics Enzymes Market Drivers
    • 2.3.3 In-vitro Diagnostics Enzymes Market Challenges
    • 2.3.4 In-vitro Diagnostics Enzymes Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top In-vitro Diagnostics Enzymes Players by Market Size
    • 3.1.1 Global Top In-vitro Diagnostics Enzymes Players by Revenue (2015-2020)
    • 3.1.2 Global In-vitro Diagnostics Enzymes Revenue Market Share by Players (2015-2020)
  • 3.2 Global In-vitro Diagnostics Enzymes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by In-vitro Diagnostics Enzymes Revenue
  • 3.4 Global In-vitro Diagnostics Enzymes Market Concentration Ratio
    • 3.4.1 Global In-vitro Diagnostics Enzymes Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by In-vitro Diagnostics Enzymes Revenue in 2019
  • 3.5 Key Players In-vitro Diagnostics Enzymes Area Served
  • 3.6 Key Players In-vitro Diagnostics Enzymes Product Solution and Service
  • 3.7 Date of Enter into In-vitro Diagnostics Enzymes Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 In-vitro Diagnostics Enzymes Breakdown Data by Type

  • 4.1 Global In-vitro Diagnostics Enzymes Historic Market Size by Type (2015-2020)
  • 4.2 Global In-vitro Diagnostics Enzymes Forecasted Market Size by Type (2021-2026)

5 In-vitro Diagnostics Enzymes Breakdown Data by Application

  • 5.1 Global In-vitro Diagnostics Enzymes Historic Market Size by Application (2015-2020)
  • 5.2 Global In-vitro Diagnostics Enzymes Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America In-vitro Diagnostics Enzymes Market Size (2015-2026)
  • 6.2 North America In-vitro Diagnostics Enzymes Market Size by Type (2015-2020)
  • 6.3 North America In-vitro Diagnostics Enzymes Market Size by Application (2015-2020)
  • 6.4 North America In-vitro Diagnostics Enzymes Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe In-vitro Diagnostics Enzymes Market Size (2015-2026)
  • 7.2 Europe In-vitro Diagnostics Enzymes Market Size by Type (2015-2020)
  • 7.3 Europe In-vitro Diagnostics Enzymes Market Size by Application (2015-2020)
  • 7.4 Europe In-vitro Diagnostics Enzymes Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic

8 Asia-Pacific

  • 8.1 Asia-Pacific In-vitro Diagnostics Enzymes Market Size (2015-2026)
  • 8.2 Asia-Pacific In-vitro Diagnostics Enzymes Market Size by Type (2015-2020)
  • 8.3 Asia-Pacific In-vitro Diagnostics Enzymes Market Size by Application (2015-2020)
  • 8.4 Asia-Pacific In-vitro Diagnostics Enzymes Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia

9 Latin America

  • 9.1 Latin America In-vitro Diagnostics Enzymes Market Size (2015-2026)
  • 9.2 Latin America In-vitro Diagnostics Enzymes Market Size by Type (2015-2020)
  • 9.3 Latin America In-vitro Diagnostics Enzymes Market Size by Application (2015-2020)
  • 9.4 Latin America In-vitro Diagnostics Enzymes Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa In-vitro Diagnostics Enzymes Market Size (2015-2026)
  • 10.2 Middle East & Africa In-vitro Diagnostics Enzymes Market Size by Type (2015-2020)
  • 10.3 Middle East & Africa In-vitro Diagnostics Enzymes Market Size by Application (2015-2020)
  • 10.4 Middle East & Africa In-vitro Diagnostics Enzymes Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE

11Key Players Profiles

  • 11.1 Merck KGaA
    • 11.1.1 Merck KGaA Company Details
    • 11.1.2 Merck KGaA Business Overview
    • 11.1.3 Merck KGaA In-vitro Diagnostics Enzymes Introduction
    • 11.1.4 Merck KGaA Revenue in In-vitro Diagnostics Enzymes Business (2015-2020))
    • 11.1.5 Merck KGaA Recent Development
  • 11.2 Codexis, Inc.
    • 11.2.1 Codexis, Inc. Company Details
    • 11.2.2 Codexis, Inc. Business Overview
    • 11.2.3 Codexis, Inc. In-vitro Diagnostics Enzymes Introduction
    • 11.2.4 Codexis, Inc. Revenue in In-vitro Diagnostics Enzymes Business (2015-2020)
    • 11.2.5 Codexis, Inc. Recent Development
  • 11.3 F. Hoffmann-La Roche Ltd.
    • 11.3.1 F. Hoffmann-La Roche Ltd. Company Details
    • 11.3.2 F. Hoffmann-La Roche Ltd. Business Overview
    • 11.3.3 F. Hoffmann-La Roche Ltd. In-vitro Diagnostics Enzymes Introduction
    • 11.3.4 F. Hoffmann-La Roche Ltd. Revenue in In-vitro Diagnostics Enzymes Business (2015-2020)
    • 11.3.5 F. Hoffmann-La Roche Ltd. Recent Development
  • 11.4 Amano Enzyme Inc.
    • 11.4.1 Amano Enzyme Inc. Company Details
    • 11.4.2 Amano Enzyme Inc. Business Overview
    • 11.4.3 Amano Enzyme Inc. In-vitro Diagnostics Enzymes Introduction
    • 11.4.4 Amano Enzyme Inc. Revenue in In-vitro Diagnostics Enzymes Business (2015-2020)
    • 11.4.5 Amano Enzyme Inc. Recent Development
  • 11.5 Advanced Enzymes Technologies Ltd.
    • 11.5.1 Advanced Enzymes Technologies Ltd. Company Details
    • 11.5.2 Advanced Enzymes Technologies Ltd. Business Overview
    • 11.5.3 Advanced Enzymes Technologies Ltd. In-vitro Diagnostics Enzymes Introduction
    • 11.5.4 Advanced Enzymes Technologies Ltd. Revenue in In-vitro Diagnostics Enzymes Business (2015-2020)
    • 11.5.5 Advanced Enzymes Technologies Ltd. Recent Development
  • 11.6 Biocatalysts Ltd.
    • 11.6.1 Biocatalysts Ltd. Company Details
    • 11.6.2 Biocatalysts Ltd. Business Overview
    • 11.6.3 Biocatalysts Ltd. In-vitro Diagnostics Enzymes Introduction
    • 11.6.4 Biocatalysts Ltd. Revenue in In-vitro Diagnostics Enzymes Business (2015-2020)
    • 11.6.5 Biocatalysts Ltd. Recent Development
  • 11.7 Amicogen
    • 11.7.1 Amicogen Company Details
    • 11.7.2 Amicogen Business Overview
    • 11.7.3 Amicogen In-vitro Diagnostics Enzymes Introduction
    • 11.7.4 Amicogen Revenue in In-vitro Diagnostics Enzymes Business (2015-2020)
    • 11.7.5 Amicogen Recent Development
  • 11.8 Dyadic International
    • 11.8.1 Dyadic International Company Details
    • 11.8.2 Dyadic International Business Overview
    • 11.8.3 Dyadic International In-vitro Diagnostics Enzymes Introduction
    • 11.8.4 Dyadic International Revenue in In-vitro Diagnostics Enzymes Business (2015-2020)
    • 11.8.5 Dyadic International Recent Development
  • 11.9 BBI Solutions
    • 11.9.1 BBI Solutions Company Details
    • 11.9.2 BBI Solutions Business Overview
    • 11.9.3 BBI Solutions In-vitro Diagnostics Enzymes Introduction
    • 11.9.4 BBI Solutions Revenue in In-vitro Diagnostics Enzymes Business (2015-2020)
    • 11.9.5 BBI Solutions Recent Development
  • 11.10 Affymetrix
    • 11.10.1 Affymetrix Company Details
    • 11.10.2 Affymetrix Business Overview
    • 11.10.3 Affymetrix In-vitro Diagnostics Enzymes Introduction
    • 11.10.4 Affymetrix Revenue in In-vitro Diagnostics Enzymes Business (2015-2020)
    • 11.10.5 Affymetrix Recent Development
  • 11.11 American Laboratories
    • 10.11.1 American Laboratories Company Details
    • 10.11.2 American Laboratories Business Overview
    • 10.11.3 American Laboratories In-vitro Diagnostics Enzymes Introduction
    • 10.11.4 American Laboratories Revenue in In-vitro Diagnostics Enzymes Business (2015-2020)
    • 10.11.5 American Laboratories Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    In-vitro Diagnostics Enzymes market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global In-vitro Diagnostics Enzymes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Proteases
    Polymerase & Transcriptase
    Ribonuclease
    Others

    Market segment by Application, split into
    Pharma & Biotech
    Hospital & Diagnostic Labs
    Contract Research Organizations (CROs)
    Academic Labs

    Based on regional and country-level analysis, the In-vitro Diagnostics Enzymes market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    In the competitive analysis section of the report, leading as well as prominent players of the global In-vitro Diagnostics Enzymes market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Merck KGaA
    Codexis, Inc.
    F. Hoffmann-La Roche Ltd.
    Amano Enzyme Inc.
    Advanced Enzymes Technologies Ltd.
    Biocatalysts Ltd.
    Amicogen
    Dyadic International
    BBI Solutions
    Affymetrix

    Buy now